October 2025, Guatemala City - The iconic Tea House at La Aurora Zoo was the setting for the presentation of the new antiparasitic product that is revolutionizing the pet market: Atrevia® 360°, a state-of-the-art oral ecto-endoparasiticide that sets a new standard in comprehensive protection for dogs.
Petmedica, together with Monteco S.A., its strategic partner in Guatemala, held the official presentation in the country with a large turnout of more than 200 attendees, including veterinarians, veterinary clinic owners, and animal health professionals.
Luis Alfredo Chávez Balarezo, Petmedica's Technical Sales Manager, was responsible for presenting the main attributes and mechanism of action of Atrevia® 360°, which generated great interest among attendees due to its effectiveness and convenience. The unique combination of three active ingredients: Fluralaner, Moxidectin, and Praziquantel, currently in the process of being patented, offers prolonged action for up to 3 months against fleas, ticks, and mites, with additional protection against cestodes and heartworm. The SmartCap® technology contained in its formulation ensures excellent palatability.
The innovation of Atrevia® 360° has been recognized internationally with the Pet Innovation Award 2025 in the Preventative Pet Care category, an award given in the United States of America, validating its innovation and impact on animal welfare.
Petmedica thanks the Guatemalan veterinary community for its excellent reception and reaffirms its commitment to continue developing and delivering innovative veterinary solutions that improve the quality of life of pets.
To learn more about the complete Atrevia line, visit www.atrevia.vet.
